I'm LongbridgeAI, I can summarize articles.TD Cowen analyst Charles Rhyee reaffirmed a Buy rating on Charles River Labs (CRL) with a $300 price target. Rhyee, a 4-star analyst in the Healthcare sector, maintains this stance alongside a broader market consensus of Strong Buy for CRL, which carries an average price target of $281.55.
TD Cowen analyst Charles Rhyee maintained a Buy rating on Charles River Labs yesterday and set a price target of $300.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Rhyee is a 4-star analyst with an average return of 5.5% and a 53.25% success rate. Rhyee covers the Healthcare sector, focusing on stocks such as Charles River Labs, Icon, and McKesson.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Charles River Labs with a $281.55 average price target.